Sanofi to Acquire Provention Bio for $2.9 Billion
March 13, 2023
Sanofi has entered into an agreement to acquire Provention Bio for $25.00 per share in cash, valuing the deal at approximately $2.9 billion. The transaction will be implemented via a cash tender offer followed by a merger, with completion expected in the second quarter of 2023 subject to customary closing conditions.
- Buyers
- Sanofi
- Targets
- Provention Bio
- Industry
- Pharmaceuticals
- Location
- United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.